China (Mainland)
Premiumsupplier 
6-Hydroxy-7-methoxy-3H-quinazolin-4-one CAS NO.179688-52-9
- FOB Price: USD: 1.00-2.00 /Metric Ton Get Latest Price
- Min.Order: 5 Metric Ton
- Payment Terms: L/C,T/T
- Available Specifications:
99%(1-5)Metric Ton99%(5-20)Metric Ton
- Product Details
Keywords
- 6-Hydroxy-7-methoxy-3H-quinazolin-4-one
- CAS: 179688-52-9
- 6-Hydroxy-7-Methoxyquinazoline-4-One
Quick Details
- ProName: 6-Hydroxy-7-methoxy-3H-quinazolin-4-on...
- CasNo: 179688-52-9
- Molecular Formula: C9H8N2O3
- Appearance: White powder
- Application: Animal Pharmaceuticals
- DeliveryTime: Within 2 weeks after order confirmatio...
- PackAge: 25kg fiber drum
- Port: Qingdao Port
- ProductionCapacity: 10000 Metric Ton/Year
- Purity: 99%
- Storage: Store in cool and dry place, away from...
- Transportation: By sea
- LimitNum: 5 Metric Ton
- CAS: 179688-52-9
- MF: C9H8N2O3
Superiority
1)Product Name:Supply API Antineoplastic Agents Gefitinib CAS 184475-35-2
2) Specification: 99%
3) Testing Method: HPLC
4) Appearance: white fine powder
5) Introduction:
Gefitinib, is a drug used for certain breast, lung , and other cancers, also known as Iressa, a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, for the treatment of prior locally advanced or metastatic non-chemical treatment or unsuitable for chemotherapysmall cell lung cancer (NSCLC).
Details
1)Product Name:Supply API Antineoplastic Agents Gefitinib CAS 184475-35-2
2) Specification: 99%
3) Testing Method: HPLC
4) Appearance: white fine powder
5) Introduction:
Gefitinib, is a drug used for certain breast, lung , and other cancers, also known as Iressa, a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, for the treatment of prior locally advanced or metastatic non-chemical treatment or unsuitable for chemotherapysmall cell lung cancer (NSCLC).